Intas Pharmaceuticals challenges two Atossa endoxifen patents with PGR and IPR petitions at USPTO

ATOSSA THERAPEUTICS, INC.

Intas filed PGR petition against U.S. Patent No. 12,071,391, titled 'Methods for Making and Using Endoxifen'.
Intas also filed IPR petition against U.S. Patent No. 11,261,151, also titled 'Methods for Making and Using Endoxifen'.
Atossa intends to vigorously contest the petitions and believes the patents are valid and enforceable.
No assurance that Atossa will prevail in the USPTO proceedings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.